BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1286585)

  • 41. The Binding Mechanisms of Antibodies to DNA from Healthy Subjects and Patients with Systemic Lupus Erythematosus: The Role of Monogamous Bivalency and Fc Dependence.
    Belina ME; Spencer DM; Pisetsky DS
    Immunohorizons; 2021 Oct; 5(10):792-801. PubMed ID: 34625509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Continuous anti-dsDNA antibody apheresis in systemic lupus erythematosus.
    Suzuki K; Hara M; Ishizuka T; Hirose T; Harigai M; Kitani K; Kawagoe M; Nakamura H
    Lancet; 1990 Sep; 336(8717):753-4. PubMed ID: 1975926
    [No Abstract]   [Full Text] [Related]  

  • 43. Enhanced pepsin digestion: a novel process for purifying antibody F(ab')(2) fragments in high yield from serum.
    Jones RG; Landon J
    J Immunol Methods; 2002 May; 263(1-2):57-74. PubMed ID: 12009204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection and purification of antiidiotypic antibody against anti-DNA in intravenous immune globulin.
    Evans MJ; Suenaga R; Abdou NI
    J Clin Immunol; 1991 Sep; 11(5):291-5. PubMed ID: 1795044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adsorption of anti-dsDNA antibodies by immobilized polyanionic compounds.
    Aotsuka S; Funahashi T; Tani N; Okawa-Takatsuji M; Kinoshita M; Yokohari R
    Clin Exp Immunol; 1990 Feb; 79(2):215-20. PubMed ID: 1690096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Partial purification of anti-DNA antibodies from systemic lupus erythematosus serum by dye-ligand chromatography.
    Pollard KM; Webb J
    J Immunol Methods; 1982 Oct; 54(1):81-94. PubMed ID: 6982949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A possible link between infection with burkholderia bacteria and systemic lupus erythematosus based on epitope mimicry.
    Zhang W; Reichlin M
    Clin Dev Immunol; 2008; 2008():683489. PubMed ID: 18682819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. True antibodies to DNA in systemic lupus erythematosus: activity of Fab and F(ab')2 fragments.
    Pincus T; Kaplan AP
    Nature; 1970 Jul; 227(5256):394-5. PubMed ID: 4913713
    [No Abstract]   [Full Text] [Related]  

  • 49. Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies.
    Fredi M; Cavazzana I; Zanola A; Carabellese N; Tincani A; Mahler M; Franceschini F
    Lupus; 2017 Sep; 26(10):1121-1122. PubMed ID: 28420064
    [No Abstract]   [Full Text] [Related]  

  • 50. An anti-DNA antibody prefers damaged dsDNA over native.
    Akberova NI; Zhmurov AA; Nevzorova TA; Litvinov RI
    J Biomol Struct Dyn; 2017 Jan; 35(1):219-232. PubMed ID: 26646388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Purification of DNA antibodies using cibacron blue F3GA affinity chromatography.
    Emlen W; Burdick G
    J Immunol Methods; 1983 Aug; 62(2):205-15. PubMed ID: 6604104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specific purification of monoclonal anti-DNA antibodies from culture medium using a DNA-coupled Sepharose 4B affinity column.
    Kitagawa Y; Sasaki T
    J Immunol Methods; 1987 Jan; 96(1):7-10. PubMed ID: 3027184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A protocol for 'enhanced pepsin digestion': a step by step method for obtaining pure antibody fragments in high yield from serum.
    Jones RG; Landon J
    J Immunol Methods; 2003 Apr; 275(1-2):239-50. PubMed ID: 12667687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Affinity-column-mediated immunoenzymometric assays: influence of affinity-column ligand and valency of antibody-enzyme conjugates.
    Freytag JW; Lau HP; Wadsley JJ
    Clin Chem; 1984 Sep; 30(9):1494-8. PubMed ID: 6432364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis.
    Granito A; Muratori L; Tovoli F; Muratori P
    Nat Rev Rheumatol; 2021 Apr; 17(4):244. PubMed ID: 33462415
    [No Abstract]   [Full Text] [Related]  

  • 56. Reply to: Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis.
    Pisetsky DS; Lipsky PE
    Nat Rev Rheumatol; 2021 Apr; 17(4):245. PubMed ID: 33462416
    [No Abstract]   [Full Text] [Related]  

  • 57. Establishing a reference interval for serum anti-dsDNA antibody: A large Chinese Han population-based multi-center study.
    Deng C; Zhang S; Hu C; Li P; Wu Z; Chen S; Li J; Li L; Zhang F; Li Y
    PLoS One; 2017; 12(2):e0168871. PubMed ID: 28151970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral blood serum from healthy donors contains antibodies against the fragment of transcribed region of ribosomal repeat.
    Veiko NN; Kostyuk SV; Ermakov AV; Kalashnikova EA; Kupavtseva OA; Ryazantseva TA; Speranskii AI
    Bull Exp Biol Med; 2007 Sep; 144(3):304-8. PubMed ID: 18457021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Corrigendum to: Multiple tolerance checkpoints restrain affinity maturation of B cells expressing the germline precursor of a lupus patient-derived anti-dsDNA antibody in knock-in mice.
    El Hussien MA; Tsai CY; Satouh Y; Motooka D; Okuzaki D; Ikawa M; Kikutani H; Sakakibara S
    Int Immunol; 2022 Mar; 34(4):225. PubMed ID: 35348696
    [No Abstract]   [Full Text] [Related]  

  • 60. [Detection of anti-dsDNA-F(AB')2 antibody and evaluation of its clinical significance].
    Kou ZC; Jiang M; Yang TB
    Zhonghua Nei Ke Za Zhi; 1992 Jun; 31(6):347-9, 381. PubMed ID: 1286585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.